E.J. Cyran, Healthcare Lawyer and Partner at Fox Rothschild LLP, recently guested on PracticeCare®, a podcast devoted to help private practice owners stay private. The topic of the episode
Continue Reading When Private Equity Comes Calling, Buy Instead
In October 2025, Governor Gavin Newsom signed two sweeping laws that significantly reshape how healthcare transactions are reported and how private equity groups and hedge funds may engage with physician
Continue Reading New California Laws Reshape Healthcare Transactions and Investor Influence
A recent federal court decision has vacated the CFPB’s Medical Debt Rule, restoring the previous framework under the Fair Credit Reporting Act (FCRA). Credit reporting agencies can continue to include coded medical debt in consumer reports, and creditors may consider this information when making credit decisions. Healthcare providers should ensure compliance with FCRA requirements and stay alert for future regulatory changes, especially as some states continue to pursue their own medical debt reporting laws.
Continue Reading Court Vacates CFPB Medical Debt Rule: Key Takeaways for Providers
E.J. Cyran, Healthcare Lawyer and Partner at Fox Rothschild LLP, recently guested on PracticeCare®, a podcast devoted to help private practice owners stay private. The topic of the episode was identifying and avoiding landmines in agreements between private practices and other healthcare providers. You can listen to the episode on Apple or Spotify here: https://marketvisorygroup.com/podcast/e-j-cyran-on-landmines-in-agreements-with-other-healthcare-providers/ Contact E.J. Cyran at ecyran@foxrothschild.com or (610) 458-4963.
Continue Reading Avoiding Landmines in Agreements between Healthcare Providers
Florida’s healthcare providers and their insurers are on the verge of a significant adjustment to the state’s medical malpractice landscape. For over three decades, a controversial provision within Florida’s medical
Continue Reading Florida’s Medical Malpractice Reform: Navigating the Shifting Landscape for Providers
On February 21, the FDA announced that the shortage of semaglutide injection products has been resolved. Semaglutide has appeared on the FDA’s Drug Shortage
Continue Reading End of Semaglutide Shortage Means Big Changes for Prescribers and Compounders
E.J. Cyran, Partner at Fox Rothschild LLP, recently guested on PracticeCare®, a podcast devoted to help private practice owners stay private. The topic of the episode was identifying and
Continue Reading How Private Practices Can Avoid Landmines in Vendor AgreementsAs healthcare systems continue to adapt to an evolving landscape, the role of Advanced Practice Providers (APPs) has become increasingly important. APPs include nurse practitioners (NPs), clinical nurse specialists (CNSs)
Continue Reading The Growing Role of Advanced Practice Providers in the Healthcare IndustryOn December 11, the U.S. Department of Health and Human Services Office of Inspector General (“OIG”) published a Special Fraud Alert warning against suspect payment arrangements involving the Medicare Advantage
Continue Reading OIG Publishes Special Fraud Alert on Medicare Advantage Marketing Arrangements